Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease

AOSD Podcast

Subscribe in Parasocial

Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.

About

Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease.

Also on

Recent episodes

  • Case StudiesJul 9, 2021 · 10 min
  • Treatment Strategies & OptionsJul 9, 2021 · 15 min
  • Recognition & DiagnosisJul 9, 2021 · 13 min
  • Pathogenesis & Clinical FeaturesJul 9, 2021 · 15 min

Website · RSS feed

Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease | Parasocial